Initiative by Novo Nordisk and big5health for World Obesity Day 2024
Vienna (OTS) –The new podcast focuses on personal stories from people with obesity and their families. Experts create a scientific framework and clarify myths and facts about this chronic disease.
Just in time for World Obesity Day on March 4th, Novo Nordisk Austria and the big5health association are launching the podcast “Adipositas & Ich”. The podcast dispels prejudices about obesity, provides insight into life with the disease and conveys exciting expert knowledge.
Numerous aspects of the complex disease obesity are dealt with in six episodes. The focus is on personal stories from those affected and their relatives as well as facts, analyzes and tips from experts. The life experiences create an emotional guide through the podcast and are put into a social and medical context by experts. The topics of the first episodes range from common weight loss myths, to the role of exercise and nutrition in our modern world, to aspects such as mental health and obesity in children.
Among other things, it is discussed here why no one is to blame for the chronic illness and how important it is to treat those affected respectfully for their mental and physical well-being and successful disease management. People with obesity give a first insight into their life with the disease and experts talk about the difficulties surrounding the diagnosis and treatment of the complex clinical picture.
You can find a link to the trailer here: https://www.big5health.at/neuer-podcast-adipositas-und-ich/ The first full episode of the podcast will be released on World Obesity Day, March 4th.
Around 17 percent* of the Austrian population is already affected by obesity, and the numbers continue to rise. While care and therapy are a given for those affected by other chronic illnesses, people with obesity fight for recognition of their illness and have to pay for large parts of the treatment themselves. They also experience exclusion and contempt in many areas of their everyday lives.
“Obesity is a disease with a very high degree of complexity; social and societal aspects also play a strong role here. If we as a society want to be successful against the disease, we must above all contribute to education and destigmatization. “As a company, we also see ourselves as having a responsibility to make a contribution,” explains Dr. Aleksandar Ciric, Managing Director of Novo Nordisk Austria, the motivation for the support. Sustainability on a financial, environmental and social level is a concern for Novo Nordisk, also due to its unique ownership structure, with the “Novo Nordisk Foundation” as the main shareholder.
Karin Duderstadt, Vice President of big5health, continues: “Unfortunately, obesity is not solved by the common tip ‘Eat healthier or less and exercise more’. It is a disease about which there is a lot of misinformation circulating, about the causes and consequences, but above all what options are available to those affected. With the new podcast ‘Obesity & Me’ there is now not only a source for technically correct information, but also reports of experiences that are intended to encourage other sufferers. This way you can learn more about the disease and understand it better.“
In the long term, the project initiators would like to recruit additional partners for the project in order to provide even broader insight into the disease obesity. The podcast can be heard on all common podcast channels and is available on the big5health association website. The first episode will be released on March 4th, followed by a new episode every two weeks.
Sources
*IHS evaluation of the Austrian Health Interview Survey (ATHIS)
About Novo Nordisk Austria
Novo Nordisk is a global healthcare leader founded in 1923 and headquartered in Denmark. In Austria, Novo Nordisk is celebrating its 50th anniversary this year. We drive change with the goal of defeating serious chronic diseases. The basis for this is our many years of experience in the treatment of diabetes. We work on scientific innovations through to the cure of diseases, promote access to our products for patients worldwide and are actively committed to prevention. Novo Nordisk employs around 63,400 people in 80 countries and markets its products in around 170 countries. Further information at www.novonordisk.at
About big5health
big5health – Association for the transfer of knowledge and to increase health literacy and joy of life in chronic illnesses, in addition to certified further training for medical professional groups, also deals with the design and dissemination of awareness campaigns in the area of health prevention among the public. The association’s offerings include TV productions, podcast series and social media campaigns, as well as health education for children and young people. Diabetes and accompanying or secondary diseases have been thematic focus since the association was founded, now no longer just within Austria, but also beyond its borders.
— AT24PA00001 —
Questions & Contact:
Novo Nordisk Austria Mag. Evelyn Devuyst, MAS +436648269333 evdt@novonordisk.at
big5health Karin Duderstadt +43 676 3901852 karin.duderstadt@big5health.at
